Myriad Genetics, Inc. MYGN
Set alert
6.35 USD -0.32 -4.80%
At close · Oct 30
6.35 0.00 0.00%
After hours · Oct 30, 7:51 PM ET
6.29 Day range 6.66
2.86 52-week range 8.18
- YTD
- +3.25%
- 1 year
- -20.13%
- Open
- 6.51
- Prev close
- 6.67
- Mkt cap
- 607.38M
- Vol
- 1.50M
- Avg vol
- 2.64M
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.29
- High
- 6.66
- Forward P/E
- 71.53
- Beta
- 1.89
- Short ratio
- 4.83
- Inst. own
- 103.89%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 13.32
- 200-d avg
- 21.11
- 1y target
- 19.41
Financial health
Altman Z-Score
-0.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -1.6×
FY 2016 5y median -9.7× FY 2025
P/S 0.7×
FY 2016 5y median 1.7× FY 2025
P/B 1.6×
FY 2016 5y median 1.8× FY 2025
P/FCF -22.4×
FY 2016 5y median -8.6× FY 2025
EV/EBITDA -1.9×
FY 2016 5y median -8.1× FY 2025
EV/Sales 0.8×
FY 2016 5y median 1.9× FY 2025
FCF Yield -4.5%
FY 2016 5y median -4.5% FY 2025
Profitability
Gross Margin 69.9%
FY 2016 5y median 69.9% FY 2025
Operating Margin -8.2%
FY 2016 5y median -18.2% FY 2025
Net Margin -44.4%
FY 2016 5y median -16.5% FY 2025
ROE -99.4%
FY 2016 5y median -18.2% FY 2025
ROIC -10.8%
FY 2016 5y median -10.0% FY 2025
ROA -51.8%
FY 2016 5y median -12.4% FY 2025
Growth (YoY)
Revenue -1.6%
FY 2016 FY 2025
Operating Income 23.0%
FY 2016 FY 2025
EPS (diluted) -180.9%
FY 2016 FY 2025
Free Cash Flow 33.3%
FY 2016 FY 2025
Financial Health
Current Ratio 2.5×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 2.3×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2016 5y median -0.6× FY 2025
Interest Coverage -6.5×
FY 2016 5y median -31.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31